# Progress Status â€” stroke_hc_v8_2

> Updated: 2026-02-19 | ì „ì²´ ë¶„ì„ ì§„í–‰ í˜„í™© ë° ì‹œê°í™” ê²°ê³¼ë¬¼ ì •ë¦¬

---

## ì™„ë£Œëœ ë¶„ì„ (Completed)

### Phase 1: Pre-processing & Integration
- Pipeline (CellBender / Souporcell / Solo / scVI) âœ…
- Clustering (res=2, scvi_snn, 36 clusters) âœ…
- Annotation (anno1: 21 types, anno2: 8 compartments) âœ…
- Annotation QC (doublet/LQ/RBC ì œê±° â†’ 205,277 clean cells) âœ…
- Subset: `5_1_hc_is.qs` (131K), `5_2_is_g3.qs` (54K) âœ…

### Phase 2: Differential Abundance (MASC)
- anno2 Ã— cohort (HC vs Stroke) âœ…
- anno1 Ã— cohort âœ…
- anno2 Ã— g3 (IS only) âœ…
- anno1 Ã— g3 âœ…
- anno2 Ã— cohort (no GEM) âœ…
- anno1 Ã— cohort (no GEM) âœ…

### Phase 3: DEG (Consensus & NEBULA)
- **L1 DEG Consensus**: muscat-edgeR + muscat-DESeq2 + NEBULA (3 methods) âœ…
  - 15/20 clusters with consensus (5 skipped: insufficient methods)
- **L2 DEG**: NEBULA only (203K results) âœ… â€” muscat too sparse for g3
- **Cross-layer concordance**: 134 genes significant in both L1 and L2 âœ…
- **Pathway enrichment** (FGS genes): HALLMARK, KEGG, GOBP âœ…
- **FGS Ã— DEG overlap**: 218/241 FGS genes significant in L1 DEG âœ…

### Phase 4: CCI (Cell-Cell Interaction)

> ìƒì„¸ ë¬¸ì„œ: [`docs/claude/cci/CCI_ANALYSIS_REPORT.md`](cci/CCI_ANALYSIS_REPORT.md)

#### CellChat v1 (Method 2A: sample-wise merged â€” original)
- L1 (HC vs Stroke, anno2): 56 samples âœ…
- L2 (g3, anno2): 32 samples âœ…
- Comparison plots + pathway plots ìƒì„±ë¨, ë‹¨ **rankNet/bubble ë¯¸ìƒì„±** (merged @data ë¹”)

#### CellChat v2 (condition-level from Seurat â€” ì¬êµ¬í˜„) âœ…
- **Seuratì—ì„œ conditionë³„ ì§ì ‘ CellChat ìƒì„±** â†’ @data ì •ìƒ, ëª¨ë“  ë¹„êµ í•¨ìˆ˜ ì‘ë™
- **rankNet (information flow)**: L1 + L2 ëª¨ë‘ ì„±ê³µ âœ… â€” í•µì‹¬ ì‹ ê·œ ê²°ê³¼
  - L1: HC-dominant (TGFb, IL2, IL16) vs Stroke-dominant (RESISTIN, MIF, BAFF)
  - L2: Bad-dominant for nearly all pathways (IL1, RESISTIN, FLT3, MIF)
- **Bubble comparison**: L-R pairë³„ ì¡°ê±´ ë¹„êµ âœ…
- **Diff circles/heatmaps**: netVisual_diffInteraction + netVisual_heatmap âœ…
- **Signaling role heatmaps** (10-11): per-condition outgoing/incoming centrality âœ…
- **Signaling scatter** (12): per-celltype signaling changes between conditions âœ…
- **Signaling role scatter** (13): outgoing vs incoming per celltype âœ…
- **Pathway chord + contribution**: 9 common pathways Ã— 2 conditions = 36 PNG per layer âœ…
- **L1**: 16 main + 36 pathway + 7 scatter = **59 PNG**
- **L2**: 18 main + 36 pathway + 5 scatter = **59 PNG**
- Output: `cci/plots/cellchat_L1_cohort_v2/`, `cellchat_L2_g3_v2/`
- Scripts: `scripts/reimplement_cellchat_v2.R`, `scripts/fix_cellchat_v2_final.R`, `scripts/fix_cellchat_heatmaps.R`

#### MNN (MultiNicheNet) â€” BUG FIXED & COMPLETE âœ…
- **ì´ì „**: 6íšŒ ì‹¤í–‰ ëª¨ë‘ `group_prioritization_tbl = 0 rows`
  - ì›ì¸: contrast string format mismatch (`"Stroke-HC"` vs `"Stroke - HC"`)
  - ì˜¤ì§„: "lr_target_prior_cor sample â‰¥5 ë¶ˆì¶©ì¡±" (ì‹¤ì œë¡œëŠ” sample ì¶©ë¶„)
- **ìˆ˜ì •**: `contrasts_oi`ë¥¼ apostropheë¡œ wrapping â†’ `makeContrasts`ê°€ string literalë¡œ ì²˜ë¦¬
- **v3 ê²°ê³¼** (2026-02-19):

| Config | Cell Types | Prioritized Interactions |
|--------|-----------|-------------------------|
| L1 anno2 (HC vs Stroke) | 5 | 8,244 |
| L1 anno1 (HC vs Stroke) | 18 | 148,958 |
| L2 anno2 (g3=1 vs g3=2) | 5 | 7,600 |
| L2 anno1 (g3=1 vs g3=2) | 17 | 91,111 |

- Output: `cci/mnn/{L1_cohort_anno2_v3, L1_cohort_anno1_v3, L2_g3_anno2_v3, L2_g3_anno1_v3}/`
- ìƒì„¸: `docs/claude/cci/MNN_FAILURE_ANALYSIS.md`
- **MNN anno1 ì‹œê°í™”** (intermediates ê¸°ë°˜): L1 6 PNG + 1 PDF, L2 6 PNG + 1 PDF âœ…

### Phase 5: FGS (Feature Gene Signature)

#### Whole-dataset FGS (n=50)
- 10 methods: 9/10 succeeded (nmf_loadings FAIL) âœ…
- **Ranger best**: AUC 0.713 (xgboost 0.591, elastic_net 0.552)
- **TML**: Ranger ROC 0.869, xgbTree 0.863, GLM 0.804 âœ…
- **CMGI**: 241 genes, top: MT-CO1 (-9.21), RPS26 (+6.58), HLA-DQA2 (-6.52), IFI44L (+5.84) âœ…
- **ì‹œê°í™”**: 8 plots âœ…

#### FGS sweep
- n=100: ì™„ë£Œ âœ…
- n=200: ì™„ë£Œ âœ… (464 â†’ TBD genes)

#### Within-cell-type FGS (n=50) âœ…
- **ì „ì²´ 15 cell types ì™„ë£Œ**
- Output: `results/fgs/within_celltype/{celltype}_50_cmgi_genes.csv`
- Cell types: B_cell, CD14_Monocyte, CD16_Monocyte, CD4_S100A8_CD14, CD4_S100A8_CSF3R, CD4_T_Naive_Memory, CD8_T_Cytotoxic, CD8_Trm, cDC2, Inflammatory_Monocyte, ISG_Myeloid, MAIT, NK_cell, Plasma_cell, Treg

### Phase 6: Trajectory

#### Trajectory v2 (Slingshot + Monocle3)
- scVI UMAP, 3 compartments: Mono (72K), CD4 (51K), CD8 (35K) âœ…

| | Monocyte | CD4+ T | CD8+ T |
|---|---------|--------|--------|
| Pseudotime | 0â€“2.69 | 0â€“2.06 | 0â€“3.34 |
| Lineages | 5 | 6 | 6 |
| Cohort p | <2e-16 | <2e-16 | 5.16e-13 |
| **g3 p** | **<2e-16** | **0.028** | **0.749 (NS)** |

- Gene dynamics v1 (GAM, no batch correction): 36 genes Ã— 3 compartments âœ…
- Gene dynamics v2 (GAMM with batch correction): `analyze_gene_dynamics_v2()` êµ¬í˜„ ì™„ë£Œ âœ…

#### Gene Dynamics v3 (Batch-corrected GAMM) âœ…
- **ì „ì²´ ì™„ë£Œ**: 3 compartments Ã— 2 conditions (cohort, g3) = 6 runs
- Model: `expr ~ s(pt) + cond + s(pt, by=cond) + offset(log(nCount)) + pct.mt + s(GEM, bs="re")`
- ê° run: 36 genes â†’ 36 PNG + summary CSV
- Output: `results/trajectory_v3/{mono,cd4,cd8}/gene_dynamics_{cohort,g3}/`

#### Trajectory Effect Sizes âœ… (Phases 1-4 ì™„ë£Œ)
- Phase 1-2: ABC/rABC/RMISE effect sizes + comparison figures â†’ `trajectory_v3/analysis/`
- Phase 3: Lamian validation (chisq method) â†’ `trajectory_v3/lamian/`
- Phase 4: Pseudobulk GAMM sensitivity â†’ `trajectory_v3/pseudobulk/`
- **í•µì‹¬ ë°œê²¬**: 10 genes confirmed by all 3 methods (mono/cohort); Mono = ONLY compartment with g3 effect
- Docs: `docs/claude/trajectory/` (4 documents)

### Phase 7: MILO (Neighbourhood DA) âœ…
- **L1 (HC vs Stroke)**: 11,739 nhoods, 63% DA (p<0.1)
- **L2 (g3 Good vs Bad)**: 4,664 nhoods, 19% DA (p<0.1)
- **3-method concordance (MILO Ã— MASC Ã— scCODA)**: 14/19 cell types DA by â‰¥2 methods (L1)
- L2: CD14+ Mono only DA (MILO + scCODA concordant)
- Output: `results/milo/{L1_cohort,L2_g3}/`
- Concordance: `results/milo/L1_concordance_3methods.csv`

### Phase 8: Descriptive Figures
- 63 files v1 (UMAP, DotPlot, bars, frequency, heatmaps, pseudotime, FGS) âœ…
- 6 files v2 (paper figures: concordance heatmap, patient FGS scores, pseudobulk heatmap, DEG overlap, MILO dotplot) âœ…
- Output v2: `results/figures/v2_paper/`

### Phase 9: Compositional Analysis

#### scCODA (Bayesian Compositional) âœ…
- **L1 (HC vs Stroke)**: 14/21 cell types credible effect
  - Credible (composition significantly different): CD14+ Mono, CD16+ Mono, CD4+ T, CD4_S100A8_CSF3R, CD8+ T, CD8+ Trm, ISG+ Myeloid, ISG+ T_cell, MAIT, NK_cell, Treg, cDC2, Platelet/PLA, pDC
  - Not credible: B_cell, CD4_S100A8_CD14, Inflammatory Mono, Plasma_cell, Proliferating, cDC1, Mast_cell
  - Fallback (Mann-Whitney): Platelet/PLA most significant (p=9.7e-12, FC=14.2), MAIT (p=1.1e-10, FC=6.1)
- **L2 (g3 Good vs Bad)**: Only **CD14+ Mono** credible effect
  - All other cell types: not credible (FDR=1.0)
  - Fallback: No cell type significant after FDR correction
- **Interpretation**: L1 composition changes robust; L2 composition differences minimal (g3 effect is expression-level, not composition)
- Output: `results/sccoda/`

### Phase 10: External Validation âœ…
- **3 independent bulk datasets** validated via ssGSEA scoring
- **FGS_TOP50** (top 50 CMGI genes): consistent across all 3 datasets
  - GSE16561 (Illumina, n=63, whole blood): **AUC=0.725**, p=0.002, d=0.92
  - GSE22255 (Affy, n=40, PBMC): **AUC=0.677**, p=0.056, d=0.62
  - GSE58294 (Affy, n=92, CE stroke blood): **AUC=0.689**, p=0.007, d=0.71
- **FGS_TOP25_DOWN** (top 25 downregulated genes): strongest discriminator
  - GSE16561: **AUC=0.817**, p=1.1e-5, d=1.26
  - GSE58294: **AUC=0.888**, p=2.9e-8, d=1.65
- **Interpretation**: scRNAseq-derived FGS signature generalizes to bulk platforms, confirming biological validity
- Output: `results/external_validation/` (4 PNG + 4 CSV)

---

### Phase 11: CCI Ã— DEG Cross-Reference âœ…
- **CellChat pathways Ã— DEG consensus**: 71 CCI genes, 16 (22.5%) overlap with DEG
- 7 unique DE genes in CCI pathways: TGFB1 (ligand), IL21R, IL2RA, CXCR4, CD44, FPR3, TNFRSF1B (receptors)
- 6 pathways with DE genes: IL2, MIF, ANNEXIN, GALECTIN, TGFb, TNF
- Output: `results/cci_deg_crossref/` (6 plots + 3 CSV + summary)

### Phase 12: cNMF (Gene Programs) âœ…
- **16/16 cell types consensus completed**
- K values: 11 for most (12 types), k=8 for B_cell, Inflammatory Monocyte, MAIT, Plasma_cell
- Programs: 8-11 per cell type, 20,644 genes scored
- Total: 202,368 cells Ã— 8-11 programs each
- **Fix**: Original script had k=10 hardcoded (not in factorized range [5,8,11,14,17,20]); resolved via k_selection plot inspection
- Output: `results/cnmf/{CELLTYPE}/` + `cnmf_consensus_summary.csv`

### Phase 13: MELD (Condition Likelihood) âœ…
- **L1 (HC vs Stroke)**: Per-cell P(Stroke) computed (205K cells)
  - Highest P(Stroke): CD14+ Mono (0.889), Inflam Mono (0.869), ISG+ Myeloid (0.865)
  - Lowest: Platelet/PLA (0.393), ISG+ T_cell (0.518), pDC (0.597)
- **L2 (IS Good vs Bad)**: Per-cell P(Bad) computed (54K IS cells)
  - Highest P(Bad): CD14+ Mono (0.792), CD16+ Mono (0.760)
  - Lowest: pDC (0.595), Plasma_cell (0.610)
- **Concordant with MASC/MILO/scCODA**: Monocytes consistently most condition-associated
- Output: `results/meld/` (4 PNG + 6 CSV)

### Phase 14: Augur (Cell Type Prioritization) âœ…
- **L1 (HC vs Stroke)**: Expression-based AUC per cell type
  - Top: cDC1 (0.859), CD16+ Mono (0.856), CD14+ Mono (0.855), CD4_S100A8_CSF3R (0.835)
  - Bottom: Platelet/PLA (0.609), CD4_S100A8_CD14 (0.617), Proliferating (0.622)
- **L2 (IS Good vs Bad)**: All AUCs near 0.5 (minimal expression separability)
  - Top: CD4_S100A8_CSF3R (0.624), CD14+ Mono (0.602)
  - Most types: 0.50-0.59 (near random)
- **Interpretation**: L1 has strong expression shifts (AUC 0.6-0.86); L2 shows subtle g3 effects
- Output: `results/augur/` (3 PNG + 3 CSV)

---

## ì§„í–‰ ì¤‘ / ì‹¤íŒ¨ (In Progress / Failed)

| ë¶„ì„ | ìƒíƒœ | ì„¸ë¶€ | ë¹„ê³  |
|------|------|------|------|
| MASC anno1 Ã— project_name | ğŸ”„ ì‹¤í–‰ ì¤‘ | Low priority | |

---

## ë³´ë¥˜ / ê³„íš (Pending)

| ë¶„ì„ | ìš°ì„ ìˆœìœ„ | ë¹„ê³  |
|------|---------|------|
| Subclustering (Mono, CD4, CD8) | Medium | anno1 ì„¸ë¶„í™” |
| LIANA (CCI alternative) | Low | MNN ì‘ë™í•˜ë¯€ë¡œ ìš°ì„ ìˆœìœ„ í•˜ë½ |
| MOFA+ (multi-omics factor) | Low | Patient-level latent factors |
| scANVI (reference mapping) | Low | ì¶”ê°€ ë¶„ì„ |
| propeller / DirichletReg | Low | Additional compositional methods |
| ~~CCI Ã— DEG cross-reference~~ | ~~High~~ | âœ… ì™„ë£Œ |
| ~~MELD~~ | ~~Low~~ | âœ… ì™„ë£Œ |
| ~~Augur~~ | ~~Low~~ | âœ… ì™„ë£Œ |
| ~~cNMF re-run~~ | ~~Medium~~ | âœ… 16/16 cell types consensus completed |
| ~~External validation~~ | ~~Medium~~ | âœ… ì™„ë£Œ â€” 3 datasets |

---

## ì‹œê°í™” ê²°ê³¼ë¬¼ ìœ„ì¹˜

ëª¨ë“  ê²°ê³¼ë¬¼ì€ `results/` symlink â†’ `/data/user3/sobj/stroke_hc_v8_2`

### CCI Plots
```
results/cci/plots/
â”œâ”€â”€ cellchat_L1_cohort/          # 49 files (16 comparison + 33 pathway)
â”‚   â”œâ”€â”€ 01-08_comparison_plots   # Circle, heatmap, boxplot (PNG + PDF)
â”‚   â”œâ”€â”€ 11-12_bubble_*.png       # L-R bubble plots (merged)
â”‚   â””â”€â”€ pathways/                # pathway circle + contribution plots
â”œâ”€â”€ cellchat_L2_g3/              # 53 files (16 comparison + 37 pathway)
â”‚   â””â”€â”€ (same structure)
â”œâ”€â”€ mnn_L1_cohort_anno1/         # 6 PNG + 1 PDF + CSVs
â”‚   â”œâ”€â”€ 01_de_summary_bar.png
â”‚   â”œâ”€â”€ 02_volcano_grid.png
â”‚   â”œâ”€â”€ 03_ligand_activity_grid.png
â”‚   â”œâ”€â”€ 04_top_ligand_receiver.png
â”‚   â”œâ”€â”€ 05_circos_ligand_receiver.{pdf,png}
â”‚   â””â”€â”€ 06_ligand_receiver_heatmap.png
â”œâ”€â”€ mnn_L1_cohort_anno2/         # 11 files
â”œâ”€â”€ mnn_L2_g3_anno1/             # 6 PNG + 1 PDF + CSVs
â””â”€â”€ mnn_L2_g3_anno2/
```

### FGS Plots
```
results/fgs/plots/               # 8 PNG
â”œâ”€â”€ 01_method_auc_comparison.png
â”œâ”€â”€ 02_tml_model_comparison.png
â”œâ”€â”€ 03_tml_all_metrics.png
â”œâ”€â”€ 04_signature_importance.png
â”œâ”€â”€ 05_cmgi_top_genes.png
â”œâ”€â”€ 06_cmgi_gene_method_heatmap.png
â”œâ”€â”€ 07_meta_score_distribution.png
â””â”€â”€ 08_meta_score_by_celltype.png
```

### Trajectory Plots
```
results/trajectory_v2/           # 117 PNG (v2: GAM, no batch correction)
â”œâ”€â”€ mono/
â”‚   â”œâ”€â”€ trajectory_overview_scvi.png
â”‚   â”œâ”€â”€ pseudotime_comparison.png
â”‚   â”œâ”€â”€ pseudotime_by_celltype.png
â”‚   â””â”€â”€ gene_dynamics/           # 36 GAM plots
â”œâ”€â”€ cd4/
â””â”€â”€ cd8/

results/trajectory_v3/           # 216 PNG (v3: batch-corrected GAMM)
â”œâ”€â”€ mono/
â”‚   â”œâ”€â”€ gene_dynamics_cohort/    # 36 PNG + summary CSV
â”‚   â””â”€â”€ gene_dynamics_g3/        # 36 PNG + summary CSV
â”œâ”€â”€ cd4/
â”‚   â”œâ”€â”€ gene_dynamics_cohort/
â”‚   â””â”€â”€ gene_dynamics_g3/
â””â”€â”€ cd8/
    â”œâ”€â”€ gene_dynamics_cohort/
    â””â”€â”€ gene_dynamics_g3/
```

### scCODA
```
results/sccoda/
â”œâ”€â”€ l1_composition.csv           # Patient Ã— cell type count matrix (L1)
â”œâ”€â”€ l2_composition.csv           # Patient Ã— cell type count matrix (L2)
â”œâ”€â”€ sccoda_L1_cohort_credible.csv  # Bayesian credible effects (14/21 TRUE)
â”œâ”€â”€ sccoda_L1_cohort_fallback.csv  # Mann-Whitney fallback with FDR
â”œâ”€â”€ sccoda_L2_g3_credible.csv      # Bayesian credible effects (1/21 TRUE)
â””â”€â”€ sccoda_L2_g3_fallback.csv      # Mann-Whitney fallback with FDR
```

### MILO
```
results/milo/
â”œâ”€â”€ L1_cohort/
â”‚   â”œâ”€â”€ milo_object.rds           # 21GB milo object
â”‚   â”œâ”€â”€ da_results.csv            # 11,739 nhood DA results
â”‚   â”œâ”€â”€ 01_da_beeswarm.png
â”‚   â”œâ”€â”€ 02_da_umap.png
â”‚   â”œâ”€â”€ 03_da_volcano.png
â”‚   â””â”€â”€ 04_da_summary_barplot.png
â”œâ”€â”€ L2_g3/                        # same structure (4,664 nhoods)
â”œâ”€â”€ L1_concordance_3methods.csv   # MILO Ã— MASC Ã— scCODA cross-method
â”œâ”€â”€ L1_milo_vs_masc_scatter.png
â””â”€â”€ L1_concordance_heatmap.png
```

### Paper Figures v2
```
results/figures/v2_paper/
â”œâ”€â”€ 01_frequency_da_concordance_heatmap.png  # 3-method DA concordance
â”œâ”€â”€ 02_patient_fgs_score_cohort.png          # FGS score HC vs IS by compartment
â”œâ”€â”€ 03_patient_fgs_score_g3.png              # FGS score Good vs Bad by compartment
â”œâ”€â”€ 04_fgs_top30_patient_heatmap.png         # Top 30 genes pseudobulk heatmap
â”œâ”€â”€ 05_cross_layer_upset_bar.png             # L1âˆ©L2âˆ©FGS overlap
â”œâ”€â”€ 05_triple_overlap_genes.csv              # 12 genes in triple overlap
â””â”€â”€ 06_milo_dual_layer_dotplot.png           # MILO L1+L2 dotplot
```

### External Validation
```
results/external_validation/
â”œâ”€â”€ 01_validation_auc_comparison.png    # AUC bar chart (5 gene sets Ã— 3 datasets)
â”œâ”€â”€ 02_validation_score_boxplot.png     # FGS_TOP50 boxplot HC vs Stroke per dataset
â”œâ”€â”€ 03_validation_roc_curves.png        # ROC curves (3 datasets overlaid)
â”œâ”€â”€ 04_validation_forest_plot.png       # Effect size forest plot
â”œâ”€â”€ validation_results_summary.csv      # Full results table (30 rows)
â”œâ”€â”€ GSE16561_ssgsea_scores.csv          # Per-sample scores
â”œâ”€â”€ GSE22255_ssgsea_scores.csv
â””â”€â”€ GSE58294_ssgsea_scores.csv
```

### cNMF (16/16 cell types consensus) âœ…
```
results/cnmf/
â”œâ”€â”€ cnmf_consensus_summary.csv    # Summary: cell_type, k, n_cells, n_programs
â”œâ”€â”€ CD4plus_T_Naive_Memory/       # k=11, 37,715 cells Ã— 11 programs
â”‚   â”œâ”€â”€ CD4plus_T_Naive_Memory.h5ad
â”‚   â””â”€â”€ CD4plus_T_Naive_Memory/
â”‚       â”œâ”€â”€ *.k_selection.png
â”‚       â”œâ”€â”€ *.usages.k_11.dt_0_1.consensus.txt
â”‚       â””â”€â”€ *.gene_spectra_score.k_11.dt_0_1.txt
â”œâ”€â”€ Inflammatory_Monocyte/        # k=8, 29,226 cells Ã— 8 programs
â”œâ”€â”€ NK_cell/                      # k=11, 25,467 cells Ã— 11 programs
â””â”€â”€ ... (16 cell types total)
```

### scCODA Plots âœ…
```
results/sccoda/plots/
â”œâ”€â”€ 01_composition_stacked_L1.png    # Cell type proportions stacked bar
â”œâ”€â”€ 02_credible_effects_dotplot.png  # L1 vs L2 credible effects
â”œâ”€â”€ 03_volcano_L1.png               # Fold change Ã— significance
â”œâ”€â”€ 04_composition_heatmap_L1.png   # Per-patient composition heatmap
â””â”€â”€ 05_composition_boxplot_L2.png   # Top 10 cell type boxplots (Good vs Bad)
```

### CCI Ã— DEG Cross-Reference âœ…
```
results/cci_deg_crossref/
â”œâ”€â”€ cellchat_deg_crossref_L1.csv    # 6 crossref hits (pathway-gene-role)
â”œâ”€â”€ pathway_deg_summary.csv         # 4 pathways with DE genes
â”œâ”€â”€ gene_cci_involvement_summary.csv # 7 unique CCI-DE genes
â”œâ”€â”€ crossref_summary.txt            # Full summary report
â””â”€â”€ plots/
    â”œâ”€â”€ 01_pathway_deg_heatmap.png
    â”œâ”€â”€ 02_pathway_compartment_dotplot.png
    â”œâ”€â”€ 03_ligand_receptor_volcano.png
    â”œâ”€â”€ 04_top_de_ligands.png
    â”œâ”€â”€ 05_top_de_receptors.png
    â””â”€â”€ 06_cci_deg_overlap.png
```

### MELD âœ…
```
results/meld/
â”œâ”€â”€ meld_L1_p_stroke.csv           # Per-cell P(Stroke) (205K cells)
â”œâ”€â”€ meld_L1_summary_by_celltype.csv # Mean P(Stroke) per cell type
â”œâ”€â”€ meld_L2_p_bad.csv              # Per-cell P(Bad) (54K IS cells)
â”œâ”€â”€ meld_L2_summary_by_celltype.csv # Mean P(Bad) per cell type
â””â”€â”€ plots/
    â”œâ”€â”€ 01_meld_L1_umap.png        # UMAP colored by P(Stroke)
    â”œâ”€â”€ 02_meld_L1_violin.png      # P(Stroke) violin per cell type
    â”œâ”€â”€ 03_meld_L2_umap.png        # UMAP colored by P(Bad)
    â””â”€â”€ 04_meld_L2_violin.png      # P(Bad) violin per cell type
```

### Augur âœ…
```
results/augur/
â”œâ”€â”€ augur_L1_auc.csv               # L1 AUC per cell type (20 types)
â”œâ”€â”€ augur_L2_auc.csv               # L2 AUC per cell type (17 types)
â”œâ”€â”€ augur_combined_auc.csv         # Both layers combined
â”œâ”€â”€ augur_L1_lollipop.png          # L1 AUC lollipop plot
â”œâ”€â”€ augur_L2_lollipop.png          # L2 AUC lollipop plot
â””â”€â”€ augur_L1_vs_L2_scatter.png     # L1 vs L2 AUC comparison scatter
```

---

## í•µì‹¬ ë°œê²¬ ìš”ì•½

1. **SIIS (Stroke-Induced Immunosuppression)**: HC ëŒ€ë¹„ Strokeì—ì„œ CCI -37%, DC hub ë¶•ê´´, cDC1 594 DE genes
2. **SIIS = Selective immunosuppression** (rankNet ì‹ ê·œ ë°œê²¬): ì „ì²´ CCI ê°ì†Œí•˜ë‚˜ RESISTIN/MIF/CypAëŠ” Strokeì—ì„œ ì¦ê°€ â†’ ì„ íƒì  ë©´ì—­ì–µì œ + ì—¼ì¦ í™œì„±í™” ë³‘ì¡´
3. **g3 Bad outcome**: ê±°ì˜ ëª¨ë“  CCI pathway ì¦ê°€ (IL1 Bad-only, RESISTIN Bad>>Good) â†’ maladaptive broad immune activation
4. **Trajectory**: g3 effectëŠ” Monoì—ì„œ ìµœê°• (p<2e-16), CD4 ì•½í•¨ (0.028), CD8 ì—†ìŒ (0.749)
5. **FGS meta-genes**: MT-CO1, HLA-DQA2 (DOWN in Bad), RPS26, IFI44L (UP in Bad)
6. **scCODA**: L1 14/21 cell types compositionally different; L2 only CD14+ Mono â†’ g3 effectëŠ” compositionì´ ì•„ë‹Œ expression level
7. **Gene dynamics v3**: 3 compartments Ã— 2 conditions, batch-corrected GAMM ì „ì²´ ì™„ë£Œ
8. **Trajectory effect sizes**: 10 genes confirmed by ALL 3 methods (ABC, Lamian, pseudobulk GAMM) in mono/cohort. Mono is ONLY compartment with g3 effect
9. **MILO 3-method concordance**: 14/19 cell types DA by â‰¥2 methods (MILO Ã— MASC Ã— scCODA) in L1. L2: only CD14+ Mono DA
10. **Cross-layer DEG overlap**: L1âˆ©L2: 82 genes, L1âˆ©FGS: 189 genes, triple overlap: 12 genes
11. **External validation**: FGS TOP50 signature (g3-derived) replicates in 3 independent bulk datasets (AUC 0.68-0.73); TOP25_DOWN achieves AUC up to 0.888
12. **MELD concordance**: P(Stroke) highest in CD14+ Mono (0.889), Inflam Mono (0.869) â€” consistent with MASC/MILO/scCODA. P(Bad outcome) also peaks in CD14+ Mono (0.792)
13. **Augur**: L1 strongly separable (AUC 0.61-0.86), L2 near random (AUC 0.50-0.62) â€” g3 effect is subtle, not global transcriptome shift
14. **cNMF**: 16 cell types Ã— 8-11 gene programs each â€” ready for condition-association analysis
15. **CCI Ã— DEG**: 22.5% of CCI pathway genes are DE; key DE signaling genes: TGFB1 (ligand), CXCR4/CD44/IL21R (receptors)

---

## docs/claude/ ë¬¸ì„œ ëª©ë¡

| # | íŒŒì¼ | ë‚´ìš© | ì‘ì„±ì¼ |
|---|------|------|--------|
| 1 | `1_STROKE_HC_V8_2_CONTEXT.md` | ì „ì²´ ë¶„ì„ ì»¨í…ìŠ¤íŠ¸, ë°ì´í„°, íŒŒì´í”„ë¼ì¸ | 2026-02-13 |
| 2 | `2_gene_dynamics_approaches.md` | GAMM ëª¨ë¸ ì„¤ê³„, two-stage pseudobulk ê³„íš | 2026-02-13 |
| 3 | `3_REFACTORING_PLAN.md` | ì½”ë“œë² ì´ìŠ¤ ë¦¬íŒ©í† ë§ ê³„íš | 2026-02-14 |
| 4 | `4_PROJECT_GOALS.md` | ë…¼ë¬¸ êµ¬ì„± ë¶„ì„ 11ê°œ í•­ëª©, ì˜ì¡´ì„±, ìš°ì„ ìˆœìœ„ | 2026-02-16 |
| 5 | `5_ANALYSIS_REPORT.md` | MASC, DEG, frequency ë“± ë¶„ì„ ê²°ê³¼ ë¦¬í¬íŠ¸ | 2026-02-17 |
| 6 | `6_ADDITIONAL_ANALYSES_PLAN.md` | ì¶”ê°€ 7ê°œ ë¶„ì„ ì‹¤í–‰ ê³„íš | 2026-02-17 |
| 7 | `7_PROGRESS_STATUS.md` | **í˜„ì¬ ë¬¸ì„œ** â€” ì „ì²´ ì§„í–‰ í˜„í™© | 2026-02-18 |
| â€” | `cci/CCI_ANALYSIS_REPORT.md` | CCI ì „ìš©: ê²°ê³¼, í•´ì„, ë¬¸ì œì , í–¥í›„ ê³„íš | 2026-02-18 |
